Print Page   |   Sign In   |   Register
Companies: Cancer Genetics, Inc. (CGIX)

Company Profile


We are a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer (theranosis). Our proprietary tests target cancers where prognosis information is critical and where predicting treatment outcomes using currently available techniques is limited. These cancers include ematological, urogenital and HPV-associated cancers. We have commercially launched MatBA -CLL and -SLL, our first proprietary microarray diagnostic tests, and seek to provide our tests and services to oncologists and pathologists at hospitals, cancer centers and physician offices, as well as to biopharmaceutical companies and clinical research organizations for their clinical trials.


Contact Information

  • 201 Route 17 North 2nd Floor
  • Rutherford, NJ 07070


Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Latest Report Jun 30, 2016 10-Q
CIK 0001349929
Fiscal Year End 12/31
OTC Marketplace Not Available

Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. 1999
Employees 51 a/o Mar 01, 2013

Service Providers

Accounting/Auditing Firm
McGladrey LLP (IA)
400 Locust St.
Suite 640
Des Moines, IA, 50309
United States

Legal Counsel
Lowenstein Sandler LLP (NJ)
65 Livingston Avenue
Roseland, NJ, 07068
United States

Investor Relations Firm
RedChip Companies, Inc.
1017 Maitland Center Commons Blvd.
Maitland, FL, 32751
United States


Community Search
Sign In